Global Dual Incidence‐Mortality Patterns of Prostate Cancer Across SDI Regions, 1990–2021: A Cross‐Sectional Study Based on Global Burden of Disease 2021
This research offers a comprehensive evaluation of the global prostate cancer landscape, with a specific focus on its incidence, mortality rates, and underlying risk factors.
Abstract
To facilitate the development of precision prevention and control measures, this research offers a comprehensive evaluation of the global prostate cancer landscape, with a specific focus on its incidence, mortality rates, and underlying risk factors.
Take Home Message Costs of non-muscle invasive bladder cancer are highly heterogeneous and strongly influenced by disease severity and early treatment. Real-world, stage-specific estimates are essential for informing cost-effectiveness analyses and guiding health care decision-making.
A. Fraslin, S. Benhamou, Thierry Lebret et al.· European Urology Open Scienc...· 0 citations
Trends in CRC‐related deaths among individuals with coexisting T2DM in the United States from 1999 to 2023 are analyzed, as well as disparities among different demographic and geographic groups are explored.
Waleed Tariq, Neha Waseem, Mehreen Maka et al.· Health Science Reports· 0 citations
Trends in the age‐ and sex‐specific burden of MM in China from 1990 to 2023, including incidence, prevalence, mortality, and disability‐adjusted life years (DALYs); projects sex‐specific incidence to 2050; and compares findings globally.
Fu Zhu, Hui-Ting Wang· Cancer Medicine· 0 citations
Brazil has substantially expanded public oncology investment over the past decade, particularly within the Brazilian Unified Health System (SUS). However, whether increased spending has translated into measurable population‐level improvements in cancer outcomes remains uncertain.
Larissa Saldanha Fonseca, Leonardo Paredes Pires, L. Alencar et al.· Cancer Medicine· 0 citations
This study aimed to provide population‐based estimates of ischemic stroke risk after cancer diagnosis across multiple cancer sites and demographic subgroups.
C. Libruder, D. Tanne, B. Silverman et al.· Cancer· 0 citations
Post-treatment surveillance in colorectal cancer (CRC) aims to detect potentially resectable recurrences, but reported adherence varies widely across studies (12%–87%)
J. Hernandez-Felix, V. Rosas-Camargo, F. D. H. Huitzil Melendez et al.· ecancermedicalscience· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
